Towards Healthcare
Musculoskeletal Disorders Treatment Market Size Envisioned at USD 326.26 Billi...

Musculoskeletal Disorders Treatment Market Size Envisioned at USD 326.26 Billion by 2032

The report covers Musculoskeletal Disorders Treatment Market Size and Companies, encompasses various segments conditions such as tendonitis, osteoarthritis, rheumatoid arthritis, carpel tunnel syndrome, fibromyalgia and other musculoskeletal disorders. Treatment options including medications like pain relievers, anti-inflammatory drugs and DMARDs, as well as implants such as joint replacement implants (hip, knee, shoulder, elbow and spinal), fracture repair implants and prosthetics like orthotics and braces. End users are hospitals, ambulatory surgical centers, clinics and home care settings. The report offers the value (in USD Billion) for the above segments.

Musculoskeletal Disorders Treatment Market Size and Overview

The musculoskeletal disorders treatment market size was valued at USD 186.02 billion in 2023 and is expected to reach USD 326.26 billion by 2032. Projected growth indicates a CAGR of 6.0% over the forecast period of 2024 - 2032.

Musculoskeletal Disorders Treatment Market Size 2023 - 2032

Unlock Infinite Advantages: Subscribe to Annual Membership

Report Highlights:

  • Osteoarthritis dominated the type segment with a 33% market share in 2023.
  • Medications took the charge with over 60% market share in 2023.
  • North America reported being the largest region with a 37% market share in 2023.

On 3 March 2024, Goa Medical College introduced India’s inaugural coated knee implants, projected to be priced under Rs.1 lakh, potentially around Rs. 80,000. The doctor highlighted its extended durability, with an expected lifespan of 30 years, surpassing the typical 15-20 years of regular implants that cost approximately Rs. 60,000 on average.

Musculoskeletal disorders are conditions that affect the muscles, bones, tendons, ligaments, and nerves in the body. These disorders can cause pain, stiffness, swelling, and limited movement in the affected area. Common examples include arthritis, tendonitis, carpal tunnel syndrome, and back pain.

Early diagnosis of musculoskeletal disorders is crucial for several reasons. It allows for prompt treatment, which can prevent the condition from worsening. Early intervention can also help alleviate symptoms and improve quality of life. Additionally, identifying musculoskeletal disorders early on can prevent further damage to the affected tissues and reduce the risk of long-term complications.

For instance,

  • In May 2021, during the Florida Orthopedic Society Annual Scientific Meeting, Echolight introduced Radiofrequency echographic multispectrometry (REMS), a portable bone densitometer utilizing radiation-free technology. REMS enables the frequent and safe monitoring of bone health indicators, offering a distinct advantage over alternative methods.

Appropriate treatment for Musculoskeletal disorders depends on the specific condition and its severity.

For instance,

  • In January 2024, the FDA recently approved a novel medication named Abrocitinib (marketed as Cibinqo) for the treatment of rheumatoid arthritis. Abrocitinib falls under the category of Janus kinase (JAK) inhibitors, targeting specific pathways within the immune system that contribute to inflammation. This approval introduces a fresh approach to managing symptoms associated with rheumatoid arthritis.

It may include a combination of medication, physical therapy, exercise, ergonomic modifications, and in some cases, surgery. Medications such as anti-inflammatories and pain relievers can help manage symptoms, while physical therapy can improve strength, flexibility, and function. Ergonomic modifications, such as adjusting workstations or using supportive devices, can also help alleviate strain on affected areas.

For instance,

  • In February 2023, Roche announced an extended partnership with Janssen Biotech Inc. to develop tests that match specific therapies. This collaboration is focused on enhancing research and innovation efforts.

Musculoskeletal disorders are disorders that affect the musculoskeletal system, causing pain and limited mobility. Early diagnosis is important because it allows for prompt treatment, which can prevent the condition from worsening and improve the quality of life. Appropriate treatment may include medication, physical therapy, exercise, and ergonomic modifications tailored to the individual's specific condition and needs.

Sedentary lifestyles Increased Musculoskeletal Disorder

Musculoskeletal disorders like arthritis, osteoporosis, and back pain are becoming more common worldwide. One big reason is that our population is aging. As people get older, their bones and joints can wear down, leading to conditions like arthritis and osteoporosis.

  • In 2021, the National Osteoporosis Foundation reported that among the 44 million Americans with weakened bones and nearly 10 million with osteoporosis, the risk of fracture elevated. Approximately 54 million individuals over 50 face a heightened risk of bone fractures, necessitating a focus on their bone health.

Arthritis Diagnosis and Projections

Another factor is our increasingly sedentary lifestyles. Many people spend a lot of time sitting at desks or on couches, which can weaken muscles and put strain on joints, leading to back pain and other musculoskeletal disorders. Obesity is also a big contributor. Carrying extra weight puts more pressure on our joints, especially those in the back, hips, and knees. This can increase the risk of developing arthritis and other musculoskeletal disorders.

Because more people are experiencing these problems, there's a greater demand for treatments and therapies to help manage the pain and improve mobility. This includes medications, physical therapy, and sometimes surgery. To address these rising needs, researchers and healthcare providers are constantly looking for new and better ways to treat musculoskeletal disorders. This might involve developing new drugs, improving surgical techniques, or finding innovative ways to deliver physical therapy.

As per the findings of the Arthritis Society, the report indicates that more than half (52%) of Canadians diagnosed with osteoarthritis are under the age of 65, nearly 4 million Canadians, equating to approximately one in seven adults, are affected by osteoarthritis. Due to this trend, there is an anticipated expansion in research investment within this field in the foreseeable future. As our population ages our lifestyles become more sedentary and obesity rates rise, the demand for treatments for musculoskeletal disorders continues to grow. This drives ongoing research and innovation in the field to improve the quality of life for those affected by these conditions.

Patient Highly Adopting Non-invasive Treatment

Patients nowadays prefer treatments that don't involve cutting them open or causing too much disruption to their bodies. They like options that let them recover faster and with fewer problems. This trend is pushing doctors and scientists to come up with new ways to treat diseases and injuries without being too invasive.

Non-invasive treatments are those that don't require surgery or breaking the skin. They might include things like physical therapy, medications, or injections. Minimally invasive treatments are ones where doctors use small incisions or tools to perform procedures. Examples include laparoscopic surgery or arthroscopic procedures for joint problems. Patients like these approaches because they often mean less pain, shorter hospital stays, and quicker recoveries. They also tend to have fewer risks and complications compared to traditional surgeries.

To meet this demand, medical researchers are working on developing new techniques and devices that can achieve the same results as invasive procedures but with less disruption to the body. This could involve things like using advanced imaging technology to guide treatments more precisely or creating new types of medical devices that can perform procedures through smaller incisions. The shift towards non-invasive and minimally invasive treatments is driving a lot of innovation in healthcare, as doctors and scientists work to give patients the best possible options for managing their health conditions.

Government Initiatives Aim to Promote Health and Facilitate Access to Treatment for the Public

In the case of musculoskeletal health, governments run campaigns to raise awareness about conditions like arthritis or back pain. These campaigns teach people how to prevent these problems and where to get help if they have them.

Governments also provide money for research. This means scientists can study musculoskeletal disorders to find better ways to treat them. With funding, researchers can develop new medicines, therapies, or devices that make life easier for people with these conditions. Regulations are rules set by governments to ensure treatments are safe and effective. They make sure that new treatments meet certain standards before they can be used. This helps protect people from treatments that might not work or could cause harm.

Government support is vital because it helps make sure that everyone, regardless of their income or background, can get the help they need for musculoskeletal disorders. It also encourages innovation by providing resources for research and development. Government initiatives play a big role in shaping the market for musculoskeletal disorders by promoting awareness, funding research, and creating rules to ensure treatments are safe and accessible to all.

The Need for Joint Replacement Surgeries and Implants has Increased

In simple terms, when we talk about joint replacement implants, we're referring to artificial parts that can be used to replace damaged or worn-out joints in the human body, such as knees or hips. These implants are often used to alleviate pain and improve mobility in people suffering from conditions like arthritis or injuries.

For instance,

  • On March 3, 2024, Goa Medical College launched India's first coated knee implants, expected to be priced at around Rs. 80,000, boasting extended durability with a projected 30-year lifespan, surpassing standard implants lasting 15-20 years and priced at approximately Rs. 60,000 on average.

When we mention the "Musculoskeletal Disorders Market," we're talking about the industry that deals with medical products and treatments for problems related to the muscles, bones, and joints. Now, the segment increase in this market means that there's a growing demand for joint replacement implants. This could be due to various factors like an ageing population, increased awareness about treatment options or advancements in medical technology making these implants more effective and accessible.

As more people face musculoskeletal issues, the demand for joint replacement procedures and implants has grown. This is because these implants can significantly improve the lives of those suffering from such problems. The technology behind these implants is always getting better, making surgeries more successful and enhancing how patients feel after the procedures.

Complexities in Conditions Creates Difficulty in Diagnosis

Musculoskeletal disorder involves a variety of conditions affecting our bones, muscles, joints, ligaments, and tendons. The complexity arises because these disorders come in many forms, each with its unique challenges. Conditions like arthritis, osteoporosis, and back pain fall under this category. The difficulty in diagnosis stems from the fact that symptoms can be diverse and may overlap.

The treatment is truly intricate due to the personalized nature required for each disorder. What works for one person might not be suitable for another. Physicians must carefully customize treatments, considering factors like age, overall health, and specific musculoskeletal issues. Additionally, these disorders often require a multidisciplinary approach, involving orthopedic specialists, physiotherapists, and sometimes surgeons.

Furthermore, in medical complexities, the emotional and lifestyle impact on individuals with musculoskeletal disorders adds another layer of challenge. Chronic pain, mobility limitation, and the potential for long-term management create a comprehensive healthcare puzzle. Advances in research and technology aim to unravel those complexities, but a holistic understanding and personalized care remain crucial for effectively addressing musculoskeletal disorders.

Geographical Landscape

The North American musculoskeletal disorder market is fiercely competitive, featuring a multitude of companies specializing in products and services for conditions like joint and bone disorders. Key players, including medical device manufacturers and pharmaceutical giants, actively compete for market share. Their focus lies in delivering effective treatments, medications, and pioneering solutions. This competitive landscape fosters a dynamic environment, compelling companies to constantly innovate in technologies and therapies. The ultimate goal is to enhance the quality of life for individuals grappling with musculoskeletal disorders, driving a continuous cycle of research, development, and advancement in the field.

Government in the Asia Pacific region plays a pivotal role in influencing the market through healthcare policies and regulations. Local and international collaborations contribute to knowledge exchange and advancement in musculoskeletal care. Additionally, the increasing prevalence of musculoskeletal disorders has heightened the demand for effective solutions, fostering competition among market players. Technological advancement, including the development of innovative medical devices.

Competitive Landscape

The musculoskeletal disorder market involves companies that create products and services to address issues with muscles, bones, and joints. Key market players include pharmaceutical companies developing medications for pain relief and inflammation. Medical device companies create tools like braces, joint implants, and mobility aids. Physical therapy providers play a crucial role in rehabilitation. The market is competitive as companies strive to innovate with new treatments and technologies. Some focus on specific disorders like arthritis, while others offer comprehensive solutions. Research and development drive competition, with companies vying to create more effective and accessible treatments. Collaboration between pharmaceutical and medical device companies is common. Government regulations impact the market, ensuring safety and efficacy. The musculoskeletal disorder market is dynamic, with diverse players contributing to the well-being of individuals dealing with this health challenge.

Recent Developments

  • In March 2024, the Food and Drug Administration approved Jubbonti ( denosumab-bbz), a RANK ligand (RANKL) inhibitor developed by Sandoz, for the treatment of osteoporosis. This interchangeable biosimilar to Prolia (denosumab) marks a significant milestone in Sandoz’s commitment to strengthening research and innovation activities in the healthcare industry. The approval underscores the company’s dedication to advancing therapeutic options and addressing the needs of patients with osteoporosis.
  • In March 2024, the FDA approved Tyenne (tocilizumab-aazq), a biosimilar of Actemra, functioning as an interleukin-6 (IL-6) receptor antagonist. Developed by Fresenius Kabi USA, LLC, Tyenne is indicated for the treatment of rheumatoid arthritis, giant cell arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile arthritis.
  • In September 2020, Lupin launched a generic version of leflunomide in the United States aimed at treating adults suffering from active rheumatoid arthritis. This move is expected to lead to an increase in the number of individuals opting for treatments for rheumatoid arthritis.

Musculoskeletal Disorders Treatment Market Players

  • Johnson & Johnson
  • Pfizer
  • Novartis
  • Abbott Laboratories
  • Medtronic
  • Stryker Corporation
  • Hoffmann-La Roche Ltd.
  • Amgen Inc.
  • Arthrex, Inc.
  • Enovis
  • Globus Medical
  • NuVasive

Musculoskeletal Disorders Treatment Market Segments

By Type

  • Tendonitis
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Carpel Tunnel Syndrome
  • Fibromyalgia
  • Other Musculoskeletal Disorders

By Product Type

  • Medications 
    • Pain Relievers
    • Anti-inflammatory Drugs
    • DMARs
    • Other Medications
  • Implants 
    • Joint Replacement Implants 
      • Hip Implants
      • Knee Implants
      • Shoulder Implants
      • Elbow Implants
    • Spinal Implants
    • Fracture Repair Implants
  • Prosthetics
  • Orthotics
  • Braces
  • Physical Therapy Equipment

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Namrata Bukshet is not just a market researcher; she is a detective, a storyteller, and a champion for healthier lives. Her journey began with a Bachelor of Pharmacy degree and a thirst for knowledge that led her to pursue a Post Graduate Diploma in Pharmaceutical Management. Her curiosity for consumer behaviour and market trends burned bright. She delved deep into the world of lifestyle disorders, conducting extensive research that sheds light on the intricate dance between personal choices and societal pressures. This exploration culminated in a groundbreaking paper on E-Biz: Indias 1st G2B Online Portal, presented at an international conference, where her insights resonated with a global audience. But Namrata has impact extends far beyond a single paper. Her expertise has shaped the very landscape of market research and pharmaceuticals. Her keen eye for detail and unwavering commitment to understanding the why behind consumer behaviour have made her a sought-after professional in the industry. She is the decoder ring that unlocks the secrets hidden within data, the translator who turns complex trends into actionable insights. As she continues to unravel the mysteries of consumer behaviour, she paves the way for a future where healthcare is not just about treatment but about understanding the why and building a bridge to a healthier world, one insightful discovery at a time.


Musculoskeletal disorders are injuries or disorders of the muscles, nerves, cartilage, tendons, joints, and spinal discs.

North America leads the market for musculoskeletal disorders.

Complexities in the conditions create hurdles in the musculoskeletal disorder market.

World Health Organization, Centers for Disease Control and Prevention, Food and Drug Administration, ScienceDirect and International Osteoporosis Foundation.